^
    BCR-ABL1 fusion
    ALL
    ponatinib
    Sensitive
    :
    A1
    Int J Hematol - 1wk
    CRLF2 rearrangement
    ALL
    ruxolitinib
    Sensitive
    :
    C2
    Leukemia - 2wk
    No biomarker
    B Acute Lymphoblastic Leukemia
    tisagenlecleucel-T
    Sensitive
    :
    A1
    No biomarker
    Childhood B Acute Lymphoblastic Leukemia
    tisagenlecleucel-T
    Sensitive
    :
    A1
    BCR-ABL1 fusion
    ALL
    imatinib
    Sensitive
    :
    A1
    CD22 positive
    B Acute Lymphoblastic Leukemia
    inotuzumab ozogamicin
    Sensitive
    :
    A1
    BCR-ABL1 fusion
    B Acute Lymphoblastic Leukemia
    inotuzumab ozogamicin
    Sensitive
    :
    A1
    BCR-ABL1 T315I
    ALL
    ponatinib
    Sensitive
    :
    A1
    No biomarker
    ALL
    blinatumomab
    Sensitive
    :
    A1
    No biomarker
    B Acute Lymphoblastic Leukemia
    blinatumomab
    Sensitive
    :
    A1
    No biomarker
    T Acute Lymphoblastic Leukemia
    nelarabine
    Sensitive
    :
    A1
    BCR-ABL1 fusion
    ALL
    dasatinib
    Sensitive
    :
    A1
    CD19 positive
    ALL
    blinatumomab
    Sensitive
    :
    A1
    No biomarker
    ALL
    mercaptopurine
    Sensitive
    :
    A1
    No biomarker
    Childhood B Acute Lymphoblastic Leukemia
    blinatumomab
    Sensitive
    :
    A1
    CD19 positive
    B Acute Lymphoblastic Leukemia
    blinatumomab
    Sensitive
    :
    A1
    No biomarker
    B Acute Lymphoblastic Leukemia
    inotuzumab ozogamicin
    Sensitive
    :
    A1
    BCR-ABL1 V299L
    ALL
    dasatinib
    Resistant
    :
    A2
    BCR-ABL1 F317I
    ALL
    dasatinib
    Resistant
    :
    A2
    BCR-ABL1 T315I
    ALL
    dasatinib
    Resistant
    :
    A2
    BCR-ABL1 fusion
    ALL
    nilotinib
    Sensitive
    :
    A2
    BCR-ABL1 T315I
    ALL
    bosutinib
    Resistant
    :
    A2
    BCR-ABL1 T315I
    ALL
    nilotinib
    Resistant
    :
    A2
    PDGFRA fusion
    Childhood B Acute Lymphoblastic Leukemia
    dasatinib
    Sensitive
    :
    A2
    ABL2 fusion
    Childhood B Acute Lymphoblastic Leukemia
    dasatinib
    Sensitive
    :
    A2
    FGFR fusion
    Childhood B Acute Lymphoblastic Leukemia
    dasatinib
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES